BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28111717)

  • 1. A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients.
    Fogelman DR; Morris J; Xiao L; Hassan M; Vadhan S; Overman M; Javle S; Shroff R; Varadhachary G; Wolff R; Vence L; Maitra A; Cleeland C; Wang XS
    Support Care Cancer; 2017 Jun; 25(6):1809-1817. PubMed ID: 28111717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer.
    Bye A; Wesseltoft-Rao N; Iversen PO; Skjegstad G; Holven KB; Ulven S; Hjermstad MJ
    Med Oncol; 2016 Jun; 33(6):54. PubMed ID: 27119533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer.
    Ramsey ML; Talbert E; Ahn D; Bekaii-Saab T; Badi N; Bloomston PM; Conwell DL; Cruz-Monserrate Z; Dillhoff M; Farren MR; Hinton A; Krishna SG; Lesinski GB; Mace T; Manilchuk A; Noonan A; Pawlik TM; Rajasekera PV; Schmidt C; Guttridge D; Hart PA
    Pancreatology; 2019 Jan; 19(1):80-87. PubMed ID: 30497874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
    Martignoni ME; Kunze P; Hildebrandt W; Künzli B; Berberat P; Giese T; Klöters O; Hammer J; Büchler MW; Giese NA; Friess H
    Clin Cancer Res; 2005 Aug; 11(16):5802-8. PubMed ID: 16115919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancer.
    Fujiwara Y; Kobayashi T; Chayahara N; Imamura Y; Toyoda M; Kiyota N; Mukohara T; Nishiumi S; Azuma T; Yoshida M; Minami H
    PLoS One; 2014; 9(11):e113259. PubMed ID: 25411961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer.
    Aust S; Knogler T; Pils D; Obermayr E; Reinthaller A; Zahn L; Radlgruber I; Mayerhoefer ME; Grimm C; Polterauer S
    PLoS One; 2015; 10(10):e0140403. PubMed ID: 26457674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia.
    Penafuerte CA; Gagnon B; Sirois J; Murphy J; MacDonald N; Tremblay ML
    Br J Cancer; 2016 Mar; 114(6):680-7. PubMed ID: 26954714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of patients with advanced pancreatic cancer and high serum interleukin-6 levels.
    Miura T; Mitsunaga S; Ikeda M; Shimizu S; Ohno I; Takahashi H; Furuse J; Inagaki M; Higashi S; Kato H; Terao K; Ochiai A
    Pancreas; 2015 Jul; 44(5):756-63. PubMed ID: 25931255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.
    Prokopchuk O; Grünwald B; Nitsche U; Jäger C; Prokopchuk OL; Schubert EC; Friess H; Martignoni ME; Krüger A
    BMC Cancer; 2018 Feb; 18(1):128. PubMed ID: 29394913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer.
    Gasiorowska A; Talar-Wojnarowska R; Kaczka A; Borkowska A; Czupryniak L; Małecka-Panas E
    Dig Dis Sci; 2016 Apr; 61(4):1121-9. PubMed ID: 26597191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia.
    Barber MD; Fearon KC; Tisdale MJ; McMillan DC; Ross JA
    Nutr Cancer; 2001; 40(2):118-24. PubMed ID: 11962246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?
    Scheede-Bergdahl C; Watt HL; Trutschnigg B; Kilgour RD; Haggarty A; Lucar E; Vigano A
    Clin Nutr; 2012 Feb; 31(1):85-8. PubMed ID: 21855185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines.
    Naing A; Dalal S; Abdelrahim M; Wheler J; Hess K; Fu S; Hong DS; Janku F; Falchook GS; Ilustre A; Ouyang F; Kurzrock R
    Support Care Cancer; 2015 Sep; 23(9):2649-54. PubMed ID: 25680763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer.
    Ando K; Takahashi F; Kato M; Kaneko N; Doi T; Ohe Y; Koizumi F; Nishio K; Takahashi K
    PLoS One; 2014; 9(7):e102436. PubMed ID: 25010770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic cytokines in the sera of patients with pancreatic cancer.
    Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Jurkowska G
    Clin Chem Lab Med; 2005; 43(2):146-50. PubMed ID: 15843207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steep elevation of blood interleukin-6 (IL-6) associated only with late stages of cachexia in cancer patients.
    Iwase S; Murakami T; Saito Y; Nakagawa K
    Eur Cytokine Netw; 2004; 15(4):312-6. PubMed ID: 15627639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial.
    Gordon JN; Trebble TM; Ellis RD; Duncan HD; Johns T; Goggin PM
    Gut; 2005 Apr; 54(4):540-5. PubMed ID: 15753541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight loss is not associated with hyperleptinemia in humans with pancreatic cancer.
    Brown DR; Berkowitz DE; Breslow MJ
    J Clin Endocrinol Metab; 2001 Jan; 86(1):162-6. PubMed ID: 11231995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the hematopoietic cytokines SCF, IL-3, GM-CSF and M-CSF in the diagnosis of pancreatic and ampullary cancer.
    Vasiliades G; Kopanakis N; Vasiloglou M; Zografos G; Margaris H; Masselou K; Kokosi E; Liakakos T
    Int J Biol Markers; 2012 Oct; 27(3):e186-94. PubMed ID: 22865301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of cytokine levels in cachectic patients with prostate carcinoma.
    Pfitzenmaier J; Vessella R; Higano CS; Noteboom JL; Wallace D; Corey E
    Cancer; 2003 Mar; 97(5):1211-6. PubMed ID: 12599227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.